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QT interval prolongation is associated with an increased risk of ventricular arrhythmia in various conditions. Cardiac 
electrophysiologic abnormalities including QT interval prolongation are well documented in patients with advanced 
liver cirrhosis. We report two cases of patients with QT interval prolongation on preoperative electrocardiography who 
exhibited repetitive ventricular arrhythmias with significant hemodynamic deterioration during liver transplantation. 
For the treatment and prevention of ventricular arrhythmias during the intraoperative period, we performed intravenous 
administration of lidocaine and isoproterenol, corrected imbalances of electrolytes including potassium and magnesium, 
and prepared a defibrillator. These cases emphasize that preoperative recognition of QT interval prolongation and ad-
equate management to prevent fatal arrhythmias are important in patients undergoing liver transplantation. (Korean J 
Anesthesiol 2014; 67: 416-420)
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QT interval prolongation is a manifestation on an electro-
cardiogram (ECG) arising from prolonged ventricular repolar-
ization [1]. This electrophysiologic abnormality is caused not 
only by several congenital syndromes associated with inherited 
defects of cardiac ion channels but also by acquired conditions 
including electrolyte imbalance, subarachnoid hemorrhage, 
diabetic autonomic neuropathy, liver cirrhosis, and drugs which 
can slow ventricular repolarization [1,2]. The clinical consider-
ations during anesthesia for patients with QT interval prolon-
gation include the occurrence of serious arrhythmias such as 
torsades de pointes (TdP) provoked by various stimuli [3]. Since 
Day et al. [4] first reported significant QT interval prolongation 
in patients with alcoholic liver disease, several reports have pro-
vided evidence about the relationship between the prevalence of 
QT interval prolongation and the severity of liver cirrhosis. Dur-
ing liver transplantation in recipients with QT interval prolon-
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gation, the fatal arrhythmias can be triggered by surgical stress, 
electrolyte abnormalities, reperfusion injury, and various medi-
cations including anesthetics that influence the QT interval [5]. 
We herein report two cases of patients with QT interval prolon-
gation on preoperative ECG who exhibited repetitive ventricular 




A 58-year-old, 175 cm, 64 kg male patient underwent liver 
transplantation due to liver cirrhosis caused by the hepatitis B 
virus, combined with hepatocellular carcinoma (HCC). The 
patient had a history of radiofrequency ablation for HCC and 
hemostasis for variceal bleeding and had taken terlipressin and 
entecavir. A preoperative ECG revealed normal sinus rhythm, 
a nonspecific T wave abnormality, and prolonged QT interval 
(QT/QTc 452/521) (Fig. 1), and preoperative transthoracic 
echocardiography (TTE) showed a left ventricular ejection 
fraction of 60%, a relaxation abnormality of the left ventricular 
filling pattern (E/E´ = 13), and a right ventricular systolic pres-
sure of 39 mmHg. After induction of anesthesia, the patient’s 
hemodynamic variables were as follows: systemic blood pressure 
109/59 mmHg, heart rate 69 bpm, central venous pressure 15 
mmHg, and pulmonary arterial pressure 33/18 mmHg. The 
results of the initial electrolyte studies showed Na+ 136 mmol/L, 
K+ 3.2 mmol/L, Cl- 105 mmol/L, Ca2+ 4.54 mg/dl, and Mg2+ 
1.34 mg/dl; hypokalemia was observed. During dissection of 
the recipient liver, the patient was hemodynamically stable with 
the exception of occasional premature ventricular complexes 
(PVCs), and transfusions of red blood cells were performed be-
cause of an initial low hemoglobin level (9.1 g/dl) and surgical 
bleeding. In addition, magnesium sulfate 1 g was mixed with the 
running fluid and calcium chloride 300 mg was administered 
repeatedly in order to manage low levels of Mg2+ and Ca2+ re-
ported in electrolyte studies conducted at intervals of one hour.
Following removal of the recipient liver, basiliximab 20 mg 
mixed in normal saline 100 ml was intravenously administered. 
During partial clamping of the inferior vena cava, ventricular 
fibrillation with loss of the arterial pressure wave was observed 
on the ECG. After approximately thirty seconds, normal sinus 
rhythm returned with unclamping of the inferior vena cava. 
After a while, clamping of the inferior vena cava was attempted 
again, but ventricular fibrillation with hemodynamic instability 
reappeared. The inferior vena cava was thus unclamped im-
mediately, and normal sinus rhythm was then spontaneously 
restored. Thereafter, ventricular fibrillation and PVCs were 
observed intermittently regardless of clamping of the inferior 
vena cava (Fig. 2A), so intravenous lidocaine 50 or 100 mg was 
repeatedly administered to maintain normal sinus rhythm. Ac-
cording to the cardiologist’s recommendation, continuous infu-
sions of lidocaine (2 mg/kg/hr) and isoproterenol (1 μg/min) 
were initiated under the impression of TdP. The infusion dose 
of isoproterenol was gradually increased to obtain the desired 
heart rate of 90-100 bpm. In addition, in order to rapidly cope 
with ventricular arrhythmia and hemodynamic compromise, 
external multifunction electrode pads (Philips Medical Systems, 
Andover, MA, USA) for defibrillation and non-invasive pacing 
were applied to the chest of the patient before reperfusion. No 
further episodes of ventricular arrhythmia were observed after 
these preventive measures. During the reperfusion period, tran-
sient hemodynamic instability was adequately managed with in-
travenous epinephrine 100 μg. After completion of surgery, the 
patient was transferred to the intensive care unit (ICU) under 
continuous infusion of lidocaine and isoproterenol. Following 
admission to the ICU, the patient’s initial QT interval was more 
Fig. 1. QT prolongation on preoperative 
electrocardiography in the first case (heart 
rate = 80 bpm, QT/QTc = 452/521).
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prolonged (QT/QTc 520/646) compared to baseline. However, 
the QT interval gradually shortened, and further episodes of 
ventricular arrhythmia did not occur. Thus, the infusions of 
lidocaine and isoproterenol were tapered and discontinued on 
postoperative day (POD) 3 and the patient was transferred to 
the general ward on POD 5. 
Case 2
A 54-year-old, 175 cm, 66 kg male patient underwent liver 
transplantation due to alcoholic liver cirrhosis and hepatic en-
cephalopathy. The patient had a history of heavy alcoholism, 
pulmonary tuberculosis, and intestinal tuberculosis. Before sur-
gery, he was admitted to the ICU for management of aggravated 
hepatic encephalopathy. A preoperative ECG revealed normal 
sinus rhythm, right axis deviation, and prolonged QT interval 
(QT/QTc 524/612) (Fig. 3), and transthoracic TTE performed 
one month earlier had shown a left ventricular ejection fraction 
of 71%, a relaxation abnormality of the left ventricular filling 
pattern (E/A ratio = 0.84 and E/E´ = 9.7), and a right ventricular 
systolic pressure of 43.7 mmHg. After induction of anesthesia, 
the patient’s hemodynamic variables were as follows: systemic 
blood pressure 128/55 mmHg, heart rate 82 bpm, central ve-
nous pressure 9 mmHg, and pulmonary arterial pressure 29/13 
mmHg. The results of the initial electrolyte studies showed Na+ 
125.2 mmol/L, K+ 2.8 mmol/L, Cl- 110 mmol/L, Ca2+ 4.24 mg/dl, 
and Mg2+ 1.37 mg/dl; hyponatremia, hypocalcemia, and hypo-
kalemia were observed. Calcium choride 300 mg was repeatedly 
administered to correct hypocalcemia, and magnesium sulfate 
2 g was mixed with the running fluid. During the dissection 
phase, two transient episodes of ventricular tachycardia with 
hemodynamic instability occurred and PVCs were frequently 
observed (Fig. 2B). In order to maintain normal sinus rhythm, 
lidocaine 100 mg was intravenously administered twice. Under 
the impression of TdP, infusion of isoproterenol (1 μg/min) 
was initiated, and the infusion dose was gradually increased to 
establish the target heart rate of 90-100 bpm. In addition, potas-
sium replacement was initiated to correct hypokalemia. Follow-
A B
Fig. 2. Repetitive premature ventricular complexes (PVCs) (A) and ventricular tachycardia with hemodynamic instability and PVCs (B).
Fig. 3. QT prolongation on preoperative 
electrocardiography in the second case 
(heart rate = 82 bpm, QT/QTc = 524/612).
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ing these preventive managements, the patient experienced no 
further episodes of ventricular arrhythmia during the remain-
der of the operation, including the reperfusion period. After 
completion of surgery, the patient was transferred to the ICU 
under continuous infusion of isoproterenol. Following admis-
sion to the ICU, the patient’s initial QT interval was somewhat 
improved (QT/QTc 482/549) compared with the baseline value. 
The QT interval gradually shortened, and further episodes of 
ventricular arrhythmia were not observed. Hence, the infusion 
of isoproterenol was tapered and discontinued on POD 7 and 
the patient was then transferred to the general ward.
Discussion
In recent years, the concept of cirrhotic cardiomyopathy as a 
type of chronic cardiac dysfunction in patients with liver cirrho-
sis has been confirmed with an increasing amount of evidence, 
and it has been characterized by blunted ventricular response 
in stressful situations in spite of normal or augmented systolic 
function at rest, altered diastolic function, and abnormalities of 
cardiac electrophysiology including prolonged time interval be-
tween electrical and mechanical systole, QT interval prolonga-
tion, and blunted tachycardiac response to stress [6]. 
Prolonged QT interval as the typical electrophysiological 
change is observed in up to 50% of patients with liver cirrhosis 
[6]. Although the first report of QT interval prolongation was 
investigated in patients with alcoholic liver cirrhosis, it is not 
related to the etiology of liver cirrhosis [7]. A previous report 
demonstrated that the prolonged QT interval is associated with 
the severity of liver dysfunction and the circulating level of plas-
ma norepinephrine, which is related to sympathetic activity [8]. 
As increased sympathetic activity is the primary feature of the 
hyperdynamic circulatory syndrome in advanced liver disease, 
this activity has been proposed to be a cause of the prolonged 
QT interval [7]. As evidence to support this proposal, Zambruni 
et al. [9] reported that chronic administration of β-blocking 
agents shortened the QT interval in patients with prolonged QT 
interval.
It has been suggested that the prolonged QT interval is as-
sociated with portal hypertension, as the QT interval is com-
monly prolonged in both non-cirrhotic and cirrhotic patients 
with portal hypertension [10]. The pathogenetic mechanism 
by which portal hypertension may prolong the QT interval has 
been described as the dumping into the systemic circulation of 
cardiotoxic substances such as bile salts, endotoxins, cytokines, 
and insulin produced in the splanchnic area. These cardiotoxic 
materials may provoke damage of cardiac cell membranes 
and alteration of ion channels. In addition, the insertion of a 
transjugular intrahepatic portosystemic shunt (TIPS) has been 
shown to aggravate the prolonged QT interval because the por-
tosystemic shunt flow enhanced by TIPS increases the amount 
of toxic substances entering into the systemic circulation [7,10].
It has been well reported that prolonged QT interval can 
provoke fatal ventricular arrhythmias, which can result in sud-
den death [1,2]. Day et al. [4] demonstrated that the incidence 
of sudden death was greatly increased in patients with alcoholic 
liver disease and prolonged QT interval. As there is the general 
perception that sudden death is not common in patients with 
liver cirrhosis, the clinical significance of prolonged QT interval 
related to liver cirrhosis should be ascertained [7]. However, 
the incidence of these complications may be underestimated 
because ECG monitoring is not frequently performed even in 
cirrhotic patients with severe comorbidities such as bacterial in-
fections and gastrointestinal bleeding [7]. These conditions can 
lead to additional and abrupt elevations of sympathetic activity, 
and the use of drugs such as quinolones and vasopressin ana-
logues to treat them can increase the risk of arrhythmias includ-
ing TdP [7]. Therefore, adequate monitoring and management 
to prevent the fatal arrhythmias should be considered during 
anesthesia for cirrhotic patients with QT interval prolongation 
under these stressful complications. 
It has been demonstrated that TdP can occur due to myocar-
dial ischemia, electrolyte imbalance, and drugs that affect QT 
interval during liver transplantation in patients with prolonged 
QT interval [5]. In a recent study measuring QT interval during 
liver transplantation, QT interval gradually increased from the 
pre-anhepatic phase to the neohepatic phase compared to the 
baseline value, and prolonged QT interval was maintained with-
out recovery even in the neohepatic phase. In addition, severe 
prolongation of QT interval (QTc ≥ 500 ms) in the anhepatic 
phase was observed even in 36% of patients with baseline QTc 
≤ 440 ms [5]. In our cases, severe prolonged QT intervals (QTc 
= 521 and 621 ms) were observed on the preoperative ECGs of 
both patients, and the patient in the first case had a more pro-
longed QT interval compared to baseline on the postoperative 
ECG performed just after ICU admission. Thus, preoperative 
QT interval prolongation and its further increase during surgery 
might contribute to the occurrence of ventricular arrhythmia in 
our cases. 
In order to prevent severe ventricular arrhythmia in patients 
with prolonged QT interval, optimization of electrolyte balance 
and hemodynamic status is preferentially required during liver 
transplantation, and drugs that can prolong QT interval should 
be avoided as much as possible [2,5]. In addition, acceleration 
of the basal heart rate is effective to prevent the occurrence of 
TdP. Isoproterenol at a dose of 1-10 μg/min can be applied to 
increase the heart rate to the desired 90-100 bpm [11]. Cardiac 
pacing can be also considered as an effective tool to accelerate 
the heart rate [11,12].
It is concluded that the fatal ventricular arrhythmias related 
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to prolonged QT interval can occur during liver transplantation. 
Thus, these cases emphasize that preoperative recognition of QT 
interval prolongation and adequate monitoring and manage-
ment for the prevention of fatal arrhythmias are important in 
patients undergoing liver transplantation.
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